Bank of Montreal’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-101,466
| Closed | -$1.82M | – | 4500 |
|
|
2017
Q4 | $1.82M | Buy |
101,466
+8,404
| +9% | +$103K | ﹤0.01% | 1625 |
|
|
2017
Q3 | $1.1M | Buy |
93,062
+76,262
| +454% | +$855K | ﹤0.01% | 1928 |
|
|
2017
Q2 | $177K | Sell |
16,800
-7,975
| -32% | -$81.3K | ﹤0.01% | 2715 |
|
|
2017
Q1 | $272K | Buy |
24,775
+4,615
| +23% | +$53.6K | ﹤0.01% | 2329 |
|
|
2016
Q4 | $328K | Sell |
20,160
-5,858
| -23% | -$81.7K | ﹤0.01% | 2293 |
|
|
2016
Q3 | $320K | Buy |
26,018
+733
| +3% | +$8.64K | ﹤0.01% | 2261 |
|
|
2016
Q2 | $277K | Buy |
25,285
+1,824
| +8% | +$20.4K | ﹤0.01% | 2315 |
|
|
2016
Q1 | $256K | Sell |
23,461
-74
| -0.3% | -$935 | ﹤0.01% | 2330 |
|
|
2015
Q4 | $406K | Buy |
23,535
+16,708
| +245% | +$300K | ﹤0.01% | 2069 |
|
|
2015
Q3 | $136K | Sell |
6,827
-2,433
| -26% | -$55.8K | ﹤0.01% | 2454 |
|
|
2015
Q2 | $152K | Buy |
9,260
+3,650
| +65% | +$63.3K | ﹤0.01% | 2529 |
|
|
2015
Q1 | $87K | Sell |
5,610
-1,828
| -25% | -$28.3K | ﹤0.01% | 2693 |
|
|
2014
Q4 | $106K | Sell |
7,438
-1,167
| -14% | -$12.3K | ﹤0.01% | 2749 |
|
|
2014
Q3 | $56K | Sell |
8,605
-466
| -5% | -$3.1K | ﹤0.01% | 3095 |
|
|
2014
Q2 | $62K | Buy |
9,071
+471
| +5% | +$3.33K | ﹤0.01% | 3109 |
|
|
2014
Q1 | $61K | Sell |
8,600
-85
| -1% | -$727 | ﹤0.01% | 3041 |
|
|
2013
Q4 | $82K | Buy |
8,685
+1,756
| +25% | +$12.5K | ﹤0.01% | 2634 |
|
|
2013
Q3 | $43K | Buy |
+6,929
| New | +$43.3K | ﹤0.01% | 2903 |
|
Other funds holding SCMP
Bank of Montreal's SCMP Position: Q1 2018 in Review
Bank of Montreal sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 101,466 shares — an estimated $1.82M sold.
Bank of Montreal first reported a position in SCMP in Q3 2013 and held it in 18 quarters. The position peaked at $1.82M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Bank of Montreal reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Bank of Montreal sold 101,466 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.82M.
- Bank of Montreal first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2013 and held it in 18 quarters.
- Bank of Montreal's Sucampo Pharmaceuticals, Inc. position peaked at $1.82M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.